All About Cardiovascular System and Disorders

APRIL 17, 2024

Ventricular tachycardia is a potentially life threatening cardiac arrhythmia. Chronic recurrent monomorphic VT like fascicular tachycardia and right ventricular outflow tract tachycardia are also amenable to electrophysiological mapping and ablation. If the rate is very fast, hemodynamic deterioration can occur rapidly.

Tachycardia 52

Tachycardia Defibrillator Congenital Ischemia 52

DAIC

MARCH 26, 2024

The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 Pacemakers and implantable cardioverter defibrillators (ICDs) are the standard of care to regulate a patient’s irregular heartbeat. million people in the United States by 2030, based on an estimation from the Centers for Disease Control and Prevention.

Pacemaker 105

Pacemaker Heart Rhythm Arrhythmia Atrial Fibrillation 105

DAIC

JANUARY 19, 2024

“I am grateful to my ACC colleagues for recognizing our work with this prestigious award,” said Chugh, associate director of the Smidt Heart Institute and the Pauline and Harold Price Chair in Cardiac Electrophysiology Research at Cedars-Sinai. The credit goes to my mentees and colleagues over the years.

Cardiac Arrest 105

Cardiac Arrest Heart Rhythm Electrophysiology Sudden Cardiac Death 105

Circulation: Arrhythmia and Electrophysiology

JANUARY 29, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:There is no specific treatment for sudden cardiac arrest (SCA) manifesting as pulseless electric activity (PEA) and survival rates are low; unlike ventricular fibrillation (VF), which is treatable by defibrillation.

Cardiac Arrest 40

Cardiac Arrest Chest Pain Coronary Artery Disease Electrophysiology 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 21, 2024

Abstract Introduction Wearable cardioverter defibrillator (WCD) is utilized in patients with assumed but not yet confirmed risk for sudden cardiac death (SCD). However, the rate of WCD-detected ventricular or atrial arrhythmia events in this specific high-risk cohort is not well understood. events per 100 patient-years vs. 74.8

Atrial Fibrillation 40

Atrial Fibrillation Sudden Cardiac Death Arrhythmia Outcomes 40

Dr. Smith's ECG Blog

JANUARY 30, 2019

Prior to Mizusawa's study, it was thought that the incidence of syncope, arrhythmia, or SCD in this cohort was low [7]. In light of the risk of arrhythmia events observed in the Mizusawa trial, a formal EP study might be reasonable to obtain in those with fever induced asymptomatic Brugada ECG changes to help risk stratify these patients.

Heart Rhythm 52

Heart Rhythm Sudden Cardiac Death Arrhythmia STEMI 52

Dr. Smith's ECG Blog

DECEMBER 5, 2019

A score including ECG pattern, early familial SCD antecedents, inducible electrophysiological study, presentation as syncope or as aborted SCD and SND had a predictive performance of 0.82. Conclusion of this paper: Fever is a great risk factor for arrhythmia events in Brugada Syndrome patients. and proband status (HR 2.1).

Sudden Cardiac Death 52

Sudden Cardiac Death Heart Rhythm Article Tachycardia 52